← Back to headlines
PDS Biotech Accelerates Regulatory Timeline for VERSATILE-003 Protocol
PDS Biotech has outlined an accelerated regulatory timeline following an amendment to its VERSATILE-003 protocol, indicating faster progress for its clinical development.
30 Mar, 16:02 — 30 Mar, 16:02
Sources
Showing 1 of 1 sources
